Patents by Inventor Daniel Schneditz

Daniel Schneditz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12262978
    Abstract: Absolute blood volume in dialysis patients is a useful patient attribute to know for dialysis treatment, diagnosis, adjustments, etc. In some cases, it is difficult or impossible to directly determine absolute blood volume. Estimating absolute blood volume may be used to overcome the inability to directly determine the absolute blood volume. Estimating absolute blood volume may include obtaining a series of measurements of hemoconcentration of a patient over a time period, and estimating parameters for a physiological model based on the series of measurements. The absolute blood volume of the patient may be determined using the physiological model.
    Type: Grant
    Filed: December 29, 2023
    Date of Patent: April 1, 2025
    Assignees: University of Massachusetts, Analiza, Inc., Medical University of Graz
    Inventors: Yossi Chait, Joseph Horowitz, Christopher V. Hollot, Hamed Samandari, Michael J. Germain, Daniel Schneditz
  • Publication number: 20240131239
    Abstract: Absolute blood volume in dialysis patients is a useful patient attribute to know for dialysis treatment, diagnosis, adjustments, etc. In some cases, it is difficult or impossible to directly determine absolute blood volume. Estimating absolute blood volume may be used to overcome the inability to directly determine the absolute blood volume. Estimating absolute blood volume may include obtaining a series of measurements of hemoconcentration of a patient over a time period, and estimating parameters for a physiological model based on the series of measurements. The absolute blood volume of the patient may be determined using the physiological model.
    Type: Application
    Filed: December 29, 2023
    Publication date: April 25, 2024
    Inventors: Yossi Chait, Joseph Horowitz, Christopher V. Hollot, Hamed Samandari, Michael J. Germain, Daniel Schneditz
  • Patent number: 11896748
    Abstract: Absolute blood volume in dialysis patients is a useful patient attribute to know for dialysis treatment, diagnosis, adjustments, etc. In some cases, it is difficult or impossible to directly determine absolute blood volume. Estimating absolute blood volume may be used to overcome the inability to directly determine the absolute blood volume. Estimating absolute blood volume may include obtaining a series of measurements of hemoconcentration of a patient over a time period, and estimating parameters for a physiological model based on the series of measurements. The absolute blood volume of the patient may be determined using the physiological model.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: February 13, 2024
    Assignee: University of Massachusetts
    Inventors: Yossi Chait, Joseph Horowitz, Christopher V. Hollot, Hamed Samandari, Michael J. Germain, Daniel Schneditz
  • Publication number: 20200086027
    Abstract: Absolute blood volume in dialysis patients is a useful patient attribute to know for dialysis treatment, diagnosis, adjustments, etc. In some cases, it is difficult or impossible to directly determine absolute blood volume. Estimating absolute blood volume may be used to overcome the inability to directly determine the absolute blood volume. Estimating absolute blood volume may include obtaining a series of measurements of hemoconcentration of a patient over a time period, and estimating parameters for a physiological model based on the series of measurements. The absolute blood volume of the patient may be determined using the physiological model.
    Type: Application
    Filed: June 1, 2018
    Publication date: March 19, 2020
    Inventors: Yossi Chait, Joseph Horowitz, Christopher V. Hollot, Hamed Samandari, Michael J. Germain, Daniel Schneditz
  • Patent number: 7354417
    Abstract: Methods and apparatus for determining peritoneal cavity fluid volume include four groups of two electrodes applied to a subject's skin. Measuring electrodes (MLL, MRL) are applied to the subject's loins, measuring electrodes (MLB, MRB) are applied to the subject's buttocks, and upper and lower current-providing electrodes (IRU, ILU, IRL, ILL) are applied to the subject's left and right sides distal from the measuring electrodes (MLL, MRL, MLB, MRB). The resistance between left measuring electrodes (MLL, MLB) is measured and the resistance between right measuring electrodes (MRL, MRB) is measured while current is applied between the upper and lower current-providing electrodes. By averaging resistance values, in combination with a calibration procedure, measurements of peritoneal cavity fluid volume are obtained. The measurement techniques can be used in continuous flow peritoneal dialysis to control or adjust dialysis parameters based on peritoneal cavity fluid.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: April 8, 2008
    Inventors: Nathan W. Levin, Daniel Schneditz, Fansan Zhu
  • Patent number: 5830365
    Abstract: The invention relates to a means for determining hemodynamic parameters, such as cardiopulmonary recirculation, fistula flow and cardiac minute output during an extracorporeal blood treatment, in which blood is conducted to a dialyzer (3) by way of arterial branch (8, 8') of extracorporeal path (2) which is fluidly connected to a segment (9, 12) of a fistula (10), then returned by way of venous branch (11, 11') of the extracorporeal path which is fluidly connected to the other segment (12, 9) of the fistula. The hemodynamic parameters are determined by two recirculation fraction measurements taken in quick succession and which are performed automatically by the apparatus before and after the blood flow is reversed. In a computer-memory unit (22) cardiopulmonary recirculation is calculated based on the recirculation fraction during normal blood flow together with the recirculation fraction during reversed blood flow.
    Type: Grant
    Filed: July 25, 1996
    Date of Patent: November 3, 1998
    Assignee: Fresenius AG
    Inventor: Daniel Schneditz